Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and says the term “Super Intelligence” is being used in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-24T13:32:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-17T13:43:39.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:35:51.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen instead of the study record content. The header shows the 403 message and a Home button, indicating restricted access to the page.
    Difference
    20%
    Check dated 2026-09-19T20:53:21.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 has been added to the Contacts and Locations section, while Qiryat Krinitzi, Israel, 52621 has been removed. This reflects a change in the participating sites in Israel.
    Difference
    0.1%
    Check dated 2026-09-12T19:06:37.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Israel study locations were updated: a new site in Qiryat Krinitzi (52621) was added, and Tel Litwinsky (52621) was removed.
    Difference
    0.1%
    Check dated 2026-09-05T19:35:15.000Z thumbnail image

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.